Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6552
Source ID: NCT01404078
Associated Drug: Single Dose Polycap
Title: Study to Compare 2 Doses of Polycap Versus Single Dose of Polycap With or Without Pottasium
Acronym: TIPSK
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT01404078/results
Conditions: Ischemic Heart Disease|Ischemic Stroke|Peripheral Vascular Disease|Type 2 Diabetes Mellitus
Interventions: DRUG: Single Dose Polycap|DRUG: Double dose Polycap
Outcome Measures: Primary: BLOOD PRESSURE LIPIDS, Amongst patients with cardiovascular disease or type 2 diabetes, the study aims to test the safety and efficacy of giving double dose of polycap versus a single dose of polycap for 8 weeks; efficacy to lower blood pressure and elevated lipids and safety assessed as difference with tolerance to double dose of polycap compared to a single dose., 8 weeks|Tolerability of a Double Dose of Half Strength Polycap, 8 weeks | Secondary: Blood Pressure Reduction and Lipid Lowering in Type 2 Diabetics, 8 weeks
Sponsor/Collaborators: Sponsor: St. John's Research Institute | Collaborators: Population Health Research Institute
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 518
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2010-04
Completion Date: 2011-02
Results First Posted: 2014-12-01
Last Update Posted: 2014-12-01
Locations:
URL: https://clinicaltrials.gov/show/NCT01404078